Literature DB >> 14741291

Discovery of thiophene-2-carboxylic acids as potent inhibitors of HCV NS5B polymerase and HCV subgenomic RNA replication. Part 1: Sulfonamides.

Laval Chan1, Sanjoy K Das, T Jagadeeswar Reddy, Carl Poisson, Mélanie Proulx, Oswy Pereira, Marc Courchesne, Caroline Roy, Wuyi Wang, Arshad Siddiqui, Constantin G Yannopoulos, Nghe Nguyen-Ba, Denis Labrecque, Richard Bethell, Martine Hamel, Philippe Courtemanche-Asselin, Lucille L'Heureux, Maud David, Olivier Nicolas, Stéphanie Brunette, Darius Bilimoria, Jean Bédard.   

Abstract

The discovery of a novel class of HCV NS5B polymerase inhibitors, 3-arylsulfonylamino-5-phenyl-thiophene-2-carboxylic acids is described. SAR studies have yielded several potent inhibitors of HCV polymerase as well as of HCV subgenomic RNA replication in Huh-7 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14741291     DOI: 10.1016/j.bmcl.2003.10.067

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  16 in total

1.  Antiviral Candidates for Treating Hepatitis E Virus Infection.

Authors:  Natalie E Netzler; Daniel Enosi Tuipulotu; Subhash G Vasudevan; Jason M Mackenzie; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2019-05-24       Impact factor: 5.191

2.  Inhibition of dengue virus polymerase by blocking of the RNA tunnel.

Authors:  Pornwaratt Niyomrattanakit; Yen-Liang Chen; Hongping Dong; Zheng Yin; Min Qing; J Frasier Glickman; Kai Lin; Dieter Mueller; Hans Voshol; Joanne Y H Lim; Shahul Nilar; Thomas H Keller; Pei-Yong Shi
Journal:  J Virol       Date:  2010-03-17       Impact factor: 5.103

3.  Potential Drug Strategies to Target Coronaviruses.

Authors:  Kasturi Sarkar; Parames C Sil
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

4.  HCV genetics and genotypes dictate future antiviral strategies.

Authors:  Louis Papageorgiou; Chrisanthy Vlachakis; Konstantina Dragoumani; Sofia Raftopoulou; Dimitrios Brouzas; Nicolas C Nicolaides; George P Chrousos; Evangelia Charmandari; Vasileios Megalooikonomou; Dimitrios Vlachakis
Journal:  J Mol Biochem       Date:  2017-12-10

5.  Combination of pharmacophore hypothesis and molecular docking to identify novel inhibitors of HCV NS5B polymerase.

Authors:  Amaravadhi Harikishore; Enlin Li; Jia Jun Lee; Nam-Joon Cho; Ho Sup Yoon
Journal:  Mol Divers       Date:  2015-04-11       Impact factor: 2.943

6.  Selection and characterization of replicon variants dually resistant to thumb- and palm-binding nonnucleoside polymerase inhibitors of the hepatitis C virus.

Authors:  Sophie Le Pogam; Hyunsoon Kang; Seth F Harris; Vincent Leveque; Anthony M Giannetti; Samir Ali; Wen-Rong Jiang; Sonal Rajyaguru; Gisele Tavares; Connie Oshiro; Than Hendricks; Klaus Klumpp; Julian Symons; Michelle F Browner; Nick Cammack; Isabel Nájera
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  Inhibitors of the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B.

Authors:  Megan H Powdrill; Jean A Bernatchez; Matthias Götte
Journal:  Viruses       Date:  2010-09-28       Impact factor: 5.818

8.  Replication fitness and NS5B drug sensitivity of diverse hepatitis C virus isolates characterized by using a transient replication assay.

Authors:  Steven W Ludmerer; Donald J Graham; Evelyn Boots; Edward M Murray; Amy Simcoe; Eric J Markel; Jay A Grobler; Osvaldo A Flores; David B Olsen; Daria J Hazuda; Robert L LaFemina
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

9.  Selected replicon variants with low-level in vitro resistance to the hepatitis C virus NS5B polymerase inhibitor PSI-6130 lack cross-resistance with R1479.

Authors:  Samir Ali; Vincent Leveque; Sophie Le Pogam; Han Ma; Friederike Philipp; Nicole Inocencio; Mark Smith; Andre Alker; Hyunsoon Kang; Isabel Najera; Klaus Klumpp; Julian Symons; Nick Cammack; Wen-Rong Jiang
Journal:  Antimicrob Agents Chemother       Date:  2008-10-06       Impact factor: 5.191

10.  Cross-genotypic examination of hepatitis C virus polymerase inhibitors reveals a novel mechanism of action for thumb binders.

Authors:  Auda A Eltahla; Enoch Tay; Mark W Douglas; Peter A White
Journal:  Antimicrob Agents Chemother       Date:  2014-09-22       Impact factor: 5.938

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.